Our data show that SURVIVIN/BIRC5 expression was particularly higher in males with obesity; therefore, the SURVIVIN/BIRC5 oncogene could be postulated as a potential biomarker of susceptibility to HCC in male patients with obesity. The gene discussed is BIRC5; the disease is obesity disorder.